SEC Filings

SEC Filings

Filing date	Description	Form	View
Feb 02, 2023	Withdrawal of registration statement filed under the Securities Act	RW	View HTML 0001104659-23-009929.pdf 0001104659-23-009929.rtf
Feb 02, 2023	Withdrawal of registration statement filed under the Securities Act	RW	View HTML 0001104659-23-009930.pdf 0001104659-23-009930.rtf 0001104659-23-009930.xls
Feb 01, 2023	CORRESP	CORRESP	View HTML 0001104659-23-009433.pdf 0001104659-23-009433.rtf 0001104659-23-009433.xls
Feb 01, 2023	CORRESP	CORRESP	View HTML 0001104659-23-009432.pdf 0001104659-23-009432.rtf 0001104659-23-009432.xls
Jan 27, 2023	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001104659-23-007102.pdf 0001104659-23-007102.rtf 0001104659-23-007102.xls
Jan 27, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001104659-23-007172.pdf 0001104659-23-007172.rtf 0001104659-23-007172.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 20, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-000677.pdf 0000000000-23-000677.rtf
Jan 12, 2023	Registration statement for face-amount certificate companies	S-1	View HTML 0001104659-23-003466.pdf 0001104659-23-003466.rtf 0001104659-23-003466.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 28, 2022	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-22-019017.pdf 0001558370-22-019017.rtf 0001558370-22-019017.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Dec 20, 2022	Statement of changes in beneficial ownership of securities	4	View HTML 0001235802-22-000136.pdf 0001235802-22-000136.rtf 0001235802-22-000136.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE